Heart failure Flashcards
Raised levels of which parameter is indicative of a poor prognosis in heart failure
N-terminal pro-B-type natriuretic peptide
When should patients with a high NT-proBNP be referred
Patients with suspected heart failure and an NT-proBNP level above 2,000 ng/litre should be referred urgently to have a specialist assessment and transthoracic echocardiography within 2 weeks
Which factors can reduce levels of serum natriuretic peptides
Obesity
African or African-Caribbean family origin
Diuretics
ACE inhibitors, beta blockers and ARBs
Causes of raised serum natriuretic peptides besides heart failure
Age over 70 years Left ventricular hypertrophy Ischaemia Tachycardia Right ventricular overload Hypoxaemia(from PE) Renal dysfunction
1st line treatment for heart failure with reduced ejection fraction
ACE inhibitor + beta blocker
When should ACE inhibitors not be offered in suspected heart failure
If there is also clinical suspicion of a haemodynamically significant valve disease until it has been assessed by a specialist
Which parameters should be measured and monitored in ACE inhibitor therapy
Serum sodium and potassium
Renal function and blood pressure
Before and 1 to 2 weeks after starting an ACE inhibitor, and after each dose increment
Alternative to ACE inhibitors in treatment of heart failure with reduced ejection fraction
ARB
Alternative to ACE inhibitors and ARBs in treatment of heart failure with reduced ejection fraction
Consider hydralazine in combination with nitrate for people who have heart failure with reduced ejection fraction
Which medication can be added to patients who continue to have heart failure with reduced ejection fraction already on ACE inhibitors(or ARB) and a beta-blocker
Mineralocorticoid receptor antagonists
When is ivabradine recommended in management of chronic heart failure
NYHA class II to IV stable chronic heart failure with systolic dysfunction
Sinus rhythm with a HR of 75bpm or more
Combination with standard therapy
When is sacubitril valsartan recommended in management of chronic heart failure
NYHA class II to IV symptoms
Left ventricular ejection fraction of 35% or less
Patients are already taking a stable dose of angiotensin-converting enzyme(ACE) inhibitors or ARBs
When is digoxin recommended in management of chronic heart failure
Recommended for worsening or severe heart failure with reduced ejection fraction despite first-line treatment for heart failure
Why should response to medicines be closely monitored in patients with CKD and heart failure with reduced ejection fraction
Increased risk of hyperkalaemia
Management of heart failure with a preserved ejection fraction
Loop diuretics
Ca2+ blockers
Amiodarone
Which parameters should be tested in people taking amiodarone
Liver and thyroid function tests
Advice regarding vaccinations in people with heart failure
Offer annual vaccination against influenza
Vaccination against pneumococcal disease
Advice regarding salt and fluid restriction in people with heart failure
No need to routinely advise people to restrict sodium or fluid consumption
Restrict fluids for people with dilutional hyponatraemia
Reduce intake for people with high levels of salt and/or fluid consumption
Advise to avoid salt substitutes that contain potassium
Interventional procedures for heart failure
Coronary revascularisation(not routinely offered for people with reduced ejection fraction)
Cardiac transplantation(only if severe refractory symptoms or refractory cardiogenic shock)
Non-pharmacological interventions in management of heart failure
Implantable cardioverter defib and cardiac resychronisation therapy
Cardiac rehabilitation
Palliative care
Types of heart failure
Systolic/diastolic
Right-sided/Left-sided
High-output
What does systolic heart failure refer to
Inability of the myocardium to generate a sufficient cardiac output due to left ventricle not being able to contract completely
AKA heart failure with reduced ejection fraction